Bayer gets DCGI nod for intravitreal aflibercept injection, Eylea to treat diabetic macular edema Read more
EMA approves label update for Takeda’s HYQVIA, expands use to treat secondary immunodeficiencies Read more
US FDA denies approval to Mallinckrodt for Terlipressin to treat Hepatorenal Syndrome Type 1 Read more